_version_ 1783711238541279232
author Domínguez Fernández, Mercedes
Seoane Estévez, Alejandro
Lamelo Alfonsín, Fernando
Bou, German
author_facet Domínguez Fernández, Mercedes
Seoane Estévez, Alejandro
Lamelo Alfonsín, Fernando
Bou, German
author_sort Domínguez Fernández, Mercedes
collection PubMed
description
format Online
Article
Text
id pubmed-8220936
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-82209362021-06-23 Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales Domínguez Fernández, Mercedes Seoane Estévez, Alejandro Lamelo Alfonsín, Fernando Bou, German Enferm Infecc Microbiol Clin Carta Científica Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2022 2021-06-23 /pmc/articles/PMC8220936/ /pubmed/34177031 http://dx.doi.org/10.1016/j.eimc.2021.06.006 Text en © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Carta Científica
Domínguez Fernández, Mercedes
Seoane Estévez, Alejandro
Lamelo Alfonsín, Fernando
Bou, German
Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title_full Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title_fullStr Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title_full_unstemmed Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title_short Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
title_sort utilidad del test de antígenos sars-cov-2 de lumiradx™ en centros residenciales
topic Carta Científica
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220936/
https://www.ncbi.nlm.nih.gov/pubmed/34177031
http://dx.doi.org/10.1016/j.eimc.2021.06.006
work_keys_str_mv AT dominguezfernandezmercedes utilidaddeltestdeantigenossarscov2delumiradxencentrosresidenciales
AT seoaneestevezalejandro utilidaddeltestdeantigenossarscov2delumiradxencentrosresidenciales
AT lameloalfonsinfernando utilidaddeltestdeantigenossarscov2delumiradxencentrosresidenciales
AT bougerman utilidaddeltestdeantigenossarscov2delumiradxencentrosresidenciales